With the reduced IL6 levels, the p-STAT3 expression (Fig. 5K) and the metastatic potential of CRC as indicated by MMP-2 expression (Fig. 5L) were also significantly reduced. This evidence concerns the gene MMP2 and colorectal carcinoma.